Biologika und „small molecules“ beim systemischen Lupus erythematodes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s00393-020-00767-6.pdf
Reference61 articles.
1. Rose T, Dorner T (2017) Drivers of the immunopathogenesis in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 31:321–333
2. Ryden-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A et al (2016) Off-label use of rituximab for systemic lupus erythematosus in Europe. Lupus Sci Med 3:e163
3. Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377:721–731
4. Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzova D et al (2011) A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 63:3918–3930
5. Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R et al (2018) Efficacy and safety of subcutaneous belimumab in anti-double-stranded DNA-positive, hypocomplementemic patients with systemic lupus erythematosus. Arthritis Rheumatol 70:1256–1264
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoklonale Antikörper für entzündliche, autoimmune und onkologische Hauterkrankungen;Die Dermatologie;2024-09-13
2. LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis;Lupus;2024-08-09
3. The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms;European Heart Journal;2021-08-03
4. Januskinase-Inhibitoren in der Kinderrheumatologie;Arthritis und Rheuma;2021-04
5. Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases;Biomedicines;2020-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3